Phosphoenolpyruvate Carboxykinase Deficiency

662 Users are discussing this topic

PatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.

NEW - log your activity

  • Notes
    Add notes to any clinical page and create a reflective diary
  • Track
    Automatically track and log every page you have viewed
  • Print
    Print and export a summary to use in your appraisal
Click to find out more »

Phosphoenolpyruvate carboxykinase is an important enzyme in gluconeogenesis. It is found in both the cytosol and mitochondria of the liver cells. The enzyme is regulated by insulin, glucocorticoids, cyclic adenosine monophosphate (cAMP) and diet to maintain glucose homeostasis.

Two types of phosphoenolpyruvate carboxykinase exist:

  • PCK1, PEPCK1 - soluble in the cytosol.[1]
  • PCK2, PEPCK2 - soluble in the mitochondria.[2]
  • Both conditions are extremely rare.
  • They have been reported in siblings.
  • Both are autosomal recessive inheritance.
  • The enzyme mutation in PCK1 is at gene map locus 20q13.31, and in PCK2 at 14q11.2-q12.
  • Hypoglycaemia - difficulty keeping blood sugars high.
  • Drowsiness due to hypoglycaemia.
  • Failure to thrive.
  • Metabolic acidosis from accumulation of lactic acid.
  • Mild icterus with hepatomegaly.
  • Generalised muscle weakness.

Deficiency of the enzyme can cause persistent neonatal hypoglycaemia but failure of downregulation has also been linked with type 2 diabetes mellitus and, especially, maturity-onset diabetes in the young (MODY).[3]

  • Fasting provokes lactic acidosis.
  • LFTs are abnormal and liver biopsy shows giant cell hepatitis.
  • Culture of skin fibroblasts shows reduced activity of phosphoenolpyruvate carboxykinase.

Other causes of neonatal hypoglycaemia - for example:

  • Glucose-6-phosphatase deficiency
  • Fructose-1,6,-diphosphatase deficiency
  • Pyruvate carboxylase deficiency
  • Presumably, regular feeding would prevent or reduce hypoglycaemia but the impression is of a relentless disease that causes early death (within the first six months).[1][2] 
  • Autopsy shows considerable fatty infiltration of both the liver and the kidneys. Fatty infiltration of other tissues also occurs but is less marked.
  • Genetic counselling may be given as for any other autosomal recessive disorder. There is no literature about antenatal detection.

Further reading & references

  1. Phosphoenolpyruvate carboxykinase 1 - Soluble, PCK1; Online Mendelian Inheritance in Man (OMIM)
  2. Phosphoenolpyruvate carboxykinase 2 - Mitochondrial, PCK2; Online Mendelian Inheritance in Man (OMIM)
  3. Cao H, van der Veer E, Ban MR, et al; Promoter polymorphism in PCK1 (phosphoenolpyruvate carboxykinase gene) associated with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2004 Feb;89(2):898-903.

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.

Original Author:
Dr Gurvinder Rull
Current Version:
Peer Reviewer:
Dr Adrian Bonsall
Document ID:
2606 (v22)
Last Checked:
20/06/2014
Next Review:
19/06/2019

Did you find this health information useful?

Yes No

Thank you for your feedback!

Subcribe to the Patient newsletter for healthcare and news updates.

We would love to hear your feedback!

 
 
Patient Access app - find out more Patient facebook page - Like our page